Home/ Supplements/ Boswellia/ Boswellia Serrata

Boswellia Serrata

product on market Capsule Swanson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Boswellia serrata is supported by moderate evidence for its potential to reduce inflammation and support joint health. Research indicates that its active compounds may inhibit pro-inflammatory pathways. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Boswellia Serrata
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)

Other Ingredients

Gelatin Maltodextrin Microcrystalline Cellulose Calcium Palmitate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take one capsule one to two times per day with water.

Warnings & Precautions

Warning: For adults only.

Consult your physician before using this or any product if you are pregnant or nursing, taking medication or have a medical condition.

Keep out of reach of children.

Do not use if seal is broken.

Formulation Notes

Standardized to 70% organic acids and 20% boswellic acid

Additional Information

Supports joint integrity, movement and flexibility

Science-Backed Quality Since 1969

Store in a cool, dry place.

Joint health and mobility Whole herb and standardized extract

Metadata

Product Details

UPC / SKU0 87614 14010 0
DSLD Entry Date2019-06-24
Product TypeBotanical
FormCapsule
BrandSwanson
DSLD ID203602
Data Updated2026-04-11
Research

Research Evidence

33
Research Sources
55
Avg Quality
17
Systematic Review
12
Meta Analysis
3
Rct
1
Clinical Trial
A Oral herbal therapies for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
Meta Analysis Seminars in arthritis and rheumatism 2018 PubMed DOI
B Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis
Systematic Review Complementary therapies in medicine 2026 PubMed DOI
B Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Meta Analysis BMC complementary medicine and therapies 2020 PubMed DOI
B Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis
Systematic Review Frontiers in pharmacology 2022 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Meta Analysis Rheumatology international 2015 PubMed DOI
B Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2017 PubMed DOI
B Frankincense: systematic review
Systematic Review BMJ (Clinical research ed.) 2008 PubMed DOI
View all evidence for Boswellia →
Compare

Similar Products

View all Boswellia products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.